Publications by authors named "Julius Grosche"

Claim this Profile
R
RETRACTED: Naamneh et al. Structure-Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities. 2024, , 549.
Majdi Saleem Naamneh, Tatjana Momic, Michal Klazas, Julius Grosche, Johannes A Eble

Pharmaceuticals (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RETRACTED: Structure-Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities.
Majdi Saleem Naamneh, Tatjana Momic, Michal Klazas, Julius Grosche, Johannes A Eble

Pharmaceuticals (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A redox-dependent thiol-switch and a Ca binding site within the hinge region hierarchically depend on each other in α7β1 integrin regulation.
Michele F Caliandro, Felix Schmalbein, Luca Matteo Todesca, Matthias Mörgelin, Maryam Rezaei, Julius Grosche

Free Radic Biol Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular Redox Regulation of α7β Integrin-Mediated Cell Migration Is Signaled via a Dominant Thiol-Switch.
Lukas Bergerhausen, Julius Grosche, Juliane Meißner, Christina Hecker, Michele F Caliandro

Antioxidants (Basel)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
More than a syllable in fib-ROS-is: The role of ROS on the fibrotic extracellular matrix and on cellular contacts.
Julius Grosche, Juliane Meißner, Johannes A Eble

Mol Aspects Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of adhesion, migration and of α5β1 integrin in the HCT-116 colorectal cancer cells treated with the ruthenium drug NAMI-A.
Chiara Pelillo, Hilaria Mollica, Johannes A Eble, Julius Grosche, Lea Herzog

J Inorg Biochem· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis